Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
The trademark rights for these brands will be transferred to Lupin by March next year.
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
